HomeAVTE • NASDAQ
add
Aerovate Therapeutics Inc
Previous close
$1.68
Day range
$1.64 - $1.75
Year range
$1.25 - $32.42
Market cap
49.26M USD
Avg Volume
2.09M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 24.62M | 39.57% |
Net income | -23.19M | -40.35% |
Net profit margin | — | — |
Earnings per share | -0.83 | -23.88% |
EBITDA | -24.59M | -39.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 99.33M | -16.48% |
Total assets | 106.82M | -14.13% |
Total liabilities | 15.92M | 40.88% |
Total equity | 90.90M | — |
Shares outstanding | 28.81M | — |
Price to book | 0.52 | — |
Return on assets | -52.55% | — |
Return on capital | -60.99% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -23.19M | -40.35% |
Cash from operations | -23.67M | -107.22% |
Cash from investing | 8.83M | -42.55% |
Cash from financing | 471.00K | 111.21% |
Net change in cash | -14.37M | -444.25% |
Free cash flow | -15.41M | -200.33% |
About
Founded
2018
Headquarters
Website
Employees
51